Treatment of attention deficit hyperactivity disorder in adults

Expert Review of Neurotherapeutics

Volumn 5, Issue 1, 2005, Pages 107-121

  Greenfield, Brian ^a   Hechman, Lily ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

Adult; Antidepressants; Atomoxetine; Attention deficit hyperactivity disorder; Cognitive bihavioral therapy; Combined treatment; Dexamphetamine; Methylphenidate; Stimulants; Substance abuse

Indexed keywords

AMPHETAMINE; ATOMOXETINE; DESIPRAMINE; DEXAMPHETAMINE; GUANFACINE; METHYLPHENIDATE; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ANOREXIA; ANXIETY DISORDER; ANXIETY NEUROSIS; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; BRUXISM; CONFUSION; CONSTIPATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DIZZINESS; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; ERECTILE DYSFUNCTION; FATIGUE; HEADACHE; HUMAN; HYPOMANIA; INSOMNIA; IRRITABILITY; NAUSEA; ORTHOSTATIC HYPOTENSION; RATING SCALE; REVIEW; SCORING SYSTEM; SEDATION; SUSTAINED DRUG RELEASE; TACHYCARDIA; THIRST; XEROSTOMIA;

ANTIDEPRESSIVE AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CLINICAL TRIALS; COGNITIVE THERAPY; DRUG THERAPY; DRUG THERAPY, COMBINATION; EXPERT TESTIMONY; HUMANS; NICOTINE; PROPYLAMINES; SUBSTANCE-RELATED DISORDERS;

EID: 12344294481     PISSN: 14737175     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737175.5.1.107     Document Type: Review

References (56)

1. McCann BS, Roy-Byrne P. Screening and diagnostic utility of self-report attention deficit hyperactivity disorder scales in adults. Compr. Psychiatry 45(3), 175-183 (2004).
2. Mannuzza S, Klein RG, Moulton JL III. Persistence of attention-deficit/ hyperactivity disorder into adulthood: what have we learned from the prospective follow-up studies? J. Atten. Disord. 7(2), 93-100 (2003).
3. Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J. Abnorm. Psychol. 111(2), 279-289 (2002).
4. Weiss G, Hechtman LT. Hyperactive Children Grown Up: ADHD in Children, Adolescents, and Adults. Second Edition. Guilford Press, NY, USA (1993).
5. Wilens TE, Biederman J, Spencer TJ, Prince J. Pharmacotherapy of adult attention deficit/hyperactivity disorder: a review. J. Clin. Psychopharmacol. 15(4), 270-279 (1995).
6. Sachdev PS, Trollor JN. How high a dose of stimulant medication in adult attention deficit hyperactivity disorder? Aust. NZ J. Psychiatry 34(4), 645-650 (2000).
7. Wender PH, Reimherr FW, Wood D, Ward M. A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am. J. Psychiatry 142(5), 547-552 (1985).
8. Wender PH, Wolf LE, Wasserstein J. Adults with ADHD: an overview. Ann. NY Acad. Sci. 931, 1-16 (2001). Overview of attention deficit hyperactivity disorder (ADHD) in adulthood by one of the earliest pioneers in the field. The authors describe the nosology of the disorder, its prevalence, a description of the core symptoms and comorbidities, measurement, differential diagnosis, treatment and genetic etiology.
9. Wender PH. Pharmacotherapy of attention-deficit/hyperactivity disorder in adults. J. Clin. Psychiatry 59(Suppl. 7), 76-79 (1998).
10. Spencer T, Wilens T, Biederman J, Faraone SV, Ablon JS, Lapey K. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch. Gen. Psychiatry 52(6), 434-443 (1995).
11. Bouffard R, Hechtman L, Minde K, Iaboni-Kassab F. The efficacy of two different dosages of methylphenidate in treating aduls with attention-deficit hyperactivity disorder. Can. J. Psychiatry 48(8), 546-554 (2003).
12. Dorrego MF, Canevaro L, Kuzis G, Sabe L, Starkstein SE. A randomized, double-blind, crossover study of methylphenidate and lithium in adults with attention-deficit/hyperactivity disorder: preliminary findings. J. Neuropsychiatry Clin. Neurosci. 14(3), 289-295 (2002).
13. Stein M. Multisite community open label study of concerta in adolescents and adults with ADHD. 50th Anniversary Meeting of the American Academy of Child and Adolescent Psychiatry. Miami, FL, USA (2003).
14. Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/ hyperactrvity disorder. J. Clin. Psychopharmacol. 24(1), 24-29 (2004).
15. Paterson R, Douglas C, Hallmayer J, Hagan M, Krupenia Z. A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder. Aust. NZ J. Psychiatry 33(4), 494-502 (1999).
16. Horrigan JP, Barnhill LJ. Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder. J. Clin. Psychiatry 61(6), 414-417 (2000).
17. Spencer T, Biederman J, Wilens T et al. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch. Gen. Psych. 58(8), 775-782 (2001).
18. Biederman J, Spencer T, Chrisman AK, Wilens T, Tullach S, Neister R. Long-term safety and efficacy of mixed amphetamine salts extended-release for adult ADHD. Syllabus and scientific proceedings: in summary form. 157th annual Meeting of the American Psychiatric Association. NY, USA, 106, 114 (2004).
19. Wender P. Attention-deficit hyperactivity disorder in adults. Psychiatr. Clin. North Am. 21(4), 761-774 (1998).
20. Heiligenstein E, Anders J. Pemoline in adult attention deficit hyperactivity disorder: predictors of nonresponse. J. Am. Coll. Health 45(5), 225-229 (1997).
21. Spencer T, Biederman J, Wilens TE, Faraone SV. Adults with attention-deficit/hyperactivity disorder: a controversial diagnosis. J. Clin. Psychiatry 59(Suppl. 7), 59-68 (1998).
22. Michelson D, Adler L, Spencer T et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol. Psychiatry 53(2), 112-120 (2003).
23. Henderson TA, Hartman K. Aggression, mania, and hypomania induction associated with atomoxetine. Pediatrics 114(3), 895-896 (2004).
24. Wender, PH, Wood DR, Reimherr FW, Ward M. An open trial of pargyline in the treatment of attention deficit disorder, residual type. Psychiatry Res. 9(4), 329-336 (1983).
25. Higgins ES. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder. J. Fam. Pract. 48(1), 15-20 (1999).
26. Wilens TE, Biederman J, Prince J et al. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am. J. Psychiatry 153(9), 1147-1153 (1996).
27. Popper CW. Antidepressants in the treatment of attention-deficit/ hyperactivity disorder. J. Clin. Psychiatry 58(Suppl. 14), 14-31 (1997).
28. Popper CW. Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder. Child Adolesc. Psychiatr. Clin. North Am. 9(3), 605-646 (2000).
29. Wilens TE, Spencer TJ, Biederman J et al. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am. J. Psychiatry 158(2), 282-288 (2001).
30. Hedges D, Reimherr FW, Rogers A, Strong R, Wender PH. An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder. Psychopharmacol. Bull. 31(4), 779-783 (1995).
31. Adler LA, Resnick S, Kunz M, Devinsky O. Open-label trial of venlafaxine in adults with attention deficit disorder. Psychopharmacol. Bull. 31(4), 785-788 (1995).
32. Findling RL, Schwartz MA, Flannery DJ, Manos MJ. Venlafaxine in adults with attention-deficit/hyperactivity disorder: an open clinical trial. J. Clin. Psychiatry 57(5), 184-189 (1996).
33. Wilens T. Pharmacological treatment of adult ADHD. Syllabus and scientific proceedings: in summary form. 157th annual Meeting of the American Psychiatric Association. NY, USA, 38F, 48 (2004). The authors consider the comorbid relationships of ADHD and substance use disorder in adults with ADHD, as well as the risk factors for these two conditions, associated familial relationships and diagnostic and treatment guidelines.
34. Prior FH, Isbister GK, Dawson AH, Whyte IM. Serotonin toxicity with therapeutic doses of dexamphetamine and venlafaxine. Med. J. Aust. 176(5), 240-241 (2002).
35. Findling RL. Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin re-uptake inhibitors and psychostimulants in children, adolescents, and adults: a case series. J. Child Adolesc. Psychopharmacol. 6(3), 165-175 (1996).
36. Hornig-Rohan M, Amsterdam JD. Venlafaxine versus stimulant therapy in patients with dual diagnosis ADD and depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 26(3), 585-589 (2002).
37. Hechtman LT et al. Treatment of adults with ADHD and varying degrees of anxiety and depression. 50th Anniversary Meeting of the American Academy of Child and Adolescent Psychiatry. Miami, FL, USA (2003).
38. Taylor FB, Russo J. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J. Child Adolesc. Psychopharmacol. 10(4), 311-320 (2000).
39. Taylor FB, Russo J. Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. J. Clin. Psychopharmacol. 21(2), 223-228 (2001).
40. Conners CK, Levin ED, Sparrow E et al. Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). Psychopharmacol. Bull. 32(1), 67-73 (1996).
41. Levin FR, Evans SM, Kleber HD. Practical guidelines for the treatment of substance abusers with adult attention-deficit hyperactivity disorder. Psychiatr. Serv. 50(8), 1001-1003 (1999).
42. Levin FR, Evans SM, Kleber HD. Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend. 52(1), 15-25 (1998).
43. Schubiner H, Saules KK, Arfken CL et al. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp. Clin. Psychopharmacol. 10(3), 286-294 (2002).
44. Castaneda R, Levy R, Hardy M, Trujillo M. Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults. Psychiatr. Serv. 51(2), 169-171 (2000).
45. Wilens TE. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr. Clin. North Am. 27(2), 283-301 (2004).
46. Ingram S, Hechtman L, Morgenstern G. Outcome issues in ADHD: adolescent and adult long-term outcome. Ment. Retard. Dev. Disabil. Res. Rev. 5(3), 243-250 (1999).
47. Ratey JJ, Greenberg MS, Bemporad JR, Lindem KJ. Unrecognized attention-deficit hyperactivity disorder in adults presenting for out-patient psychotherapy. J. Child Adolesc. Psychopharmacol. 2(4), 267-275 (1992).
48. Weiss M, Hechtman LT, Weiss G. ADHD in Adulthood: a Guide to Current Theory, Diagnosis, and Treatment. Johns Hopkins University Press, MD, USA (1999). Richly-referenced text which considers the assessment of adults with ADHD, their comorbidities, differential diagnosis and treatment interventions such as psychoeducational, pharmacologic, psychologic, social and family approaches.
49. McDermott SP. Cognitive therapy for adults with attention-deficit/ hyperactivity disorder. In: Attention-Deficit Disorders and Comorbidities in Children, Adolescents, and Adults. Brown TE (Ed.). American Psychiatric Press, Washington DC, USA, 569-606 (2000).
50. Wilens TE, McDermott SP, Biederman J, Abrantes A, Hahesy A, Spencer TJ. Cognitive therapy in the treatment of adults with ADHD: a systematic chart review of 26 cases. J. Cogn. Pychother. 13(3), 215-226 (1999).
51. Safren S, Otto MO, Wilens T, Sprich S, Biederman J, Winethe C. Cognitive-behavioral therapy for residual ADHD in adults. Syllabus and scientific proceedings: in summary form. 157th annual Meeting of the American Psychiatric Association. NY, USA, 104, 113 (2004).
52. Safren SA, Sprich S, Chulvick S, Otto MW. Psychosocial treatments for adults with attention-deficit/hyperactivity disorder. Psychiatr. Clin. North. Am. 27(2), 349-360 (2004). Offers a comprehensive review of the needs of adults with ADHD for interventions aimed at addressing their tendency for negative cognitions, and for behavioral approaches to address their dysfunctional interactive patterns at work and home. Recent trials are also reviewed concerning psychosocial interventions for these adults.
53. Mandelbaum S, Hechtman L, Ochs E et al. Psychosocial treatment of adults with ADHD. 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. San Francisco, CA, USA (2002).
54. Wiggins D, Singh K, Getz HG, Hutchins DE. Effects of brief group intervention for adults with attention deficit/hyperactivity disorder. J. Ment. Health Couns. 21(1), 82-92 (1999).
55. Hesslinger B, Tebartz van Elst L, Nyberg E et al. Psychotherapy of attention deficit hyperactivity disorder in adults - a pilot study using a structured skills training program. Eur. Arch. Psychiatry Clin. Neurosci. 252(4), 177-184 (2002).
56. Stevenson A cognitive remediation programme for adults with attention deficit hyperactivity disorder. Aust. NZ J. Psychiatry 36(5), 610-616 (2002).